Related Experiment Video
Updated: May 17, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
Colloidal dispersions for the delivery of acyclovir: a comparative study.
Rita Cortesi1, Laura Ravani, Enea Menegatti
1Department of Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy.
Ethosomes and solid lipid nanoparticles effectively deliver acyclovir, enhancing drug diffusion with similar antiviral activity. These colloidal systems show promise for improving acyclovir cell penetration.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Nanotechnology
Background:
- Acyclovir is a key antiviral medication, but its delivery can be improved for enhanced efficacy.
- Ethosomes and solid lipid nanoparticles (SLNs) are advanced colloidal systems for drug delivery.
- Optimizing acyclovir delivery is crucial for managing viral infections like HSV-1.
Purpose of the Study:
- To comparatively evaluate ethosomes and solid lipid nanoparticles as acyclovir delivery systems.
- To assess the encapsulation efficiency, drug diffusion, and antiviral activity of acyclovir-loaded systems.
- To determine the potential of these nanocarriers in enhancing acyclovir's cell penetration.
Main Methods:
- Ethosomes prepared via spontaneous self-assembly; SLNs via homogenization and ultrasonication.
- Morphological characterization using cryo-transmission electron microscopy.
- Encapsulation efficiency, Z-potential, drug diffusion (Franz cell), and antiviral activity (plaque reduction assay) were assessed.
Main Results:
- Ethosomes achieved significantly higher encapsulation efficiency (94.2%) compared to SLNs (53.2%).
- Both systems reduced acyclovir diffusion coefficients, indicating controlled release.
- No significant difference in antiviral activity against HSV-1 was observed between free and loaded acyclovir.
Conclusions:
- Ethosomes and SLNs are effective carriers for acyclovir, enhancing its diffusion.
- The studied colloidal systems demonstrate potential for improving acyclovir's penetration into Vero cells.
- Further research into these nanocarrier systems could advance antiviral therapy.
Related Concept Videos
In Vitro Drug Dissolution: Alternative Methods
In Vitro Drug Dissolution: Compendial Testing Models II
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
In Vitro Drug Dissolution: Compendial Testing Models I
Oral Drug Delivery Systems: Delayed-Release Systems
Colloids and Suspensions
